Skip to main content
    L

    Lifestance Health Group Inc (LFST)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $14.48
    +0.40 (+2.84%)

    Market Cap: $5.35B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Lifestance Health Group Inc (LFST) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Lifestance Health Group reported revenue of $1.42B for the fiscal year ended Dec 31, 2025, up 13.9% from the year before. That year, net income was $9.66M with a net margin of 0.7%, operating cash flow was $146.15M and free cash flow was $110.03M. The quarter ended Sep 30, 2026 had revenue of $455.86M and net income of $22.39M.

    Revenue and Margins

    The operating margin was 1.7% in the fiscal year ended Dec 2025. Over the 6 years to Dec 2025, revenue grew from $212.52M, a compound annual rate of 37.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.42B+13.9%100.0%1.7%0.7%
    Dec 2024$1.25B+18.5%100.0%-2.5%-4.6%
    Dec 2023$1.06B+22.8%100.0%-17.9%-17.6%
    Dec 2022$859.54M+28.8%100.0%-24.5%-25.1%
    Dec 2021$667.51M+77.0%100.0%-42.9%-46.0%
    Dec 2020$377.22M+77.5%35.6%4.1%-10.1%
    Dec 2019$212.52MN/A100.0%7.2%2.7%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 1973.1% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$1.42B$1.25B$1.06B$859.54M$667.51M$377.22M$212.52M
    Cost of revenue$0$0$0$0$0$242.90M$0
    Gross profit$1.42B$1.25B$1.06B$859.54M$667.51M$134.32M$212.52M
    Operating income$24.15M-$31.61M-$189.13M-$210.17M-$286.35M$15.44M$15.24M
    Net income$9.66M-$57.44M-$186.26M-$215.56M-$307.20M-$38.07M$5.67M
    EBITDA$79.80M$41.54M-$102.83M-$141.66M-$238.26MN/A$20.09M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$455.86M$435.35M$403.48M$382.19M$363.81M$345.31M$332.97M$325.48M$312.72M$312.33M$300.44M$280.60M
    Gross profit$455.86M$435.35M$403.48M$382.19M$363.81M$345.31M$332.97M$325.48M$312.72M$312.33M$300.44M$280.60M
    Operating income$33.08M$30.65M$22.28M$18.08M$7.41M-$2.95M$1.60M$1.06M$47.00K-$15.95M-$16.77M-$32.27M
    Net income$22.39M$23.61M$14.24M$11.67M$1.08M-$3.79M$709.00K-$7.11M-$5.96M-$23.28M-$21.10M-$44.96M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $311.47M exceeded cash and equivalents by $62.83M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$2.20B$2.12B$2.11B$2.17B$1.93B$1.57B$280.78M
    Current assets$416.20M$312.51M$225.73M$233.22M$266.52M$76.28M$27.43M
    Cash and equivalents$248.64M$154.57M$78.82M$108.62M$148.03M$18.83M$3.48M
    Total liabilities$682.92M$672.01M$681.04M$655.15M$382.08M$536.89M$447.13M
    Short-term debt$45.54M$0$8.17M$15.88M$14.12M$10.56M$844.00K
    Long-term debt$265.93M$279.79M$280.29M$225.08M$157.42M$362.53M$79.31M
    Shareholder equity$1.52B$1.45B$1.43B$1.52B$1.55B$997.84M-$166.35M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$2.19B$2.18B$2.15B$2.20B$2.15B$2.15B$2.10B$2.12B$2.11B$2.12B$2.11B$2.11B
    Total liabilities$693.89M$704.35M$668.47M$682.92M$656.23M$672.88M$647.57M$672.01M$670.85M$689.32M$677.32M$681.04M
    Cash and equivalents$218.82M$225.94M$194.80M$248.64M$203.90M$188.93M$134.34M$154.57M$102.61M$86.97M$49.45M$78.82M
    Shareholder equity$1.49B$1.48B$1.48B$1.52B$1.49B$1.47B$1.46B$1.45B$1.44B$1.43B$1.43B$1.43B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 75.3% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow$146.15M$107.26M-$16.88M$52.79M$9.42M-$8.53M$17.05M
    Capital expenditures$36.13M$21.57M$40.52M$79.25M$94.49M$38.07M$14.31M
    Free cash flow$110.03M$85.69M-$57.40M-$26.47M-$85.07M-$46.60M$2.73M
    Investing cash flow-$36.13M-$21.57M-$60.34M-$139.46M-$194.08M-$861.17M-$73.38M
    Financing cash flow-$15.96M-$9.95M$47.43M$47.26M$313.86M$912.27M$48.46M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$37.02M$99.91M$33.11M$57.56M$27.29M$64.40M-$3.09M$62.32M$22.72M$44.06M-$21.84M$16.80M
    Capital expenditures$14.65M$11.99M$10.77M$10.91M$10.29M$7.75M$7.17M$6.30M$5.05M$5.11M$5.10M$11.41M
    Free cash flow$22.36M$87.92M$22.34M$46.65M$17.00M$56.64M-$10.26M$56.02M$17.67M$38.95M-$26.94M$5.38M
    Last 12 quarters

    Frequently Asked Questions About LFST

    What is Lifestance Health Group's annual revenue?

    Lifestance Health Group reported revenue of $1.42B for the fiscal year ended Dec 31, 2025.

    How fast is Lifestance Health Group's revenue growing?

    Revenue was up 13.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 18.3%.

    Is Lifestance Health Group profitable?

    Yes. Lifestance Health Group reported net income of $9.66M for the fiscal year ended Dec 31, 2025, with a net margin of 0.7%.

    How much free cash flow does LFST generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $146.15M minus capital expenditures of $36.13M produced free cash flow of $110.03M.

    How much debt does Lifestance Health Group have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $265.93M, short-term debt of $45.54M and cash and equivalents of $248.64M.